These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11443124)

  • 1. 5-azaC treatment enhances expression of transforming growth factor-beta receptors through down-regulation of Sp3.
    Ammanamanchi S; Brattain MG
    J Biol Chem; 2001 Aug; 276(35):32854-9. PubMed ID: 11443124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sp3 is a transcriptional repressor of transforming growth factor-beta receptors.
    Ammanamanchi S; Brattain MG
    J Biol Chem; 2001 Feb; 276(5):3348-52. PubMed ID: 11027677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of transforming growth factor-beta receptor type II expression in estrogen receptor-positive breast cancer cells through SP1 activation by 5-aza-2'-deoxycytidine.
    Ammanamanchi S; Kim SJ; Sun LZ; Brattain MG
    J Biol Chem; 1998 Jun; 273(26):16527-34. PubMed ID: 9632722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repression of transforming growth factor-beta receptor type I promoter expression by Sp1 deficiency.
    Periyasamy S; Ammanamanchi S; Tillekeratne MP; Brattain MG
    Oncogene; 2000 Sep; 19(40):4660-7. PubMed ID: 11030155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restoration of transforming growth factor-beta signaling through receptor RI induction by histone deacetylase activity inhibition in breast cancer cells.
    Ammanamanchi S; Brattain MG
    J Biol Chem; 2004 Jul; 279(31):32620-5. PubMed ID: 15155736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acetylated sp3 is a transcriptional activator.
    Ammanamanchi S; Freeman JW; Brattain MG
    J Biol Chem; 2003 Sep; 278(37):35775-80. PubMed ID: 12837748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of Sp1 in the differential expression of transforming growth factor-beta receptor type II in human breast adenocarcinoma MCF-7 cells.
    Liu Y; Zhong X; Li W; Brattain MG; Banerji SS
    J Biol Chem; 2000 Apr; 275(16):12231-6. PubMed ID: 10766860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of decreased expression of transforming growth factor-beta receptor type I at late stages of HPV16-mediated transformation.
    Hypes MK; Pirisi L; Creek KE
    Cancer Lett; 2009 Sep; 282(2):177-86. PubMed ID: 19344999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced expression of transforming growth factor beta type I receptor contributes to the malignancy of human colon carcinoma cells.
    Wang J; Han W; Zborowska E; Liang J; Wang X; Willson JK; Sun L; Brattain MG
    J Biol Chem; 1996 Jul; 271(29):17366-71. PubMed ID: 8663343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of human type II collagen gene expression by transforming growth factor-beta 1 (TGF-beta 1) in articular chondrocytes involves SP3/SP1 ratio.
    Chadjichristos C; Ghayor C; Herrouin JF; Ala-Kokko L; Suske G; Pujol JP; Galéra P
    J Biol Chem; 2002 Nov; 277(46):43903-17. PubMed ID: 12186868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversion of transcriptional repression of Sp1 by 5 aza-2' deoxycytidine restores TGF-beta type II receptor expression in the pancreatic cancer cell line MIA PaCa-2.
    Venkatasubbarao K; Ammanamanchi S; Brattain MG; Mimari D; Freeman JW
    Cancer Res; 2001 Aug; 61(16):6239-47. PubMed ID: 11507078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple and essential Sp1 binding sites in the promoter for transforming growth factor-beta type I receptor.
    Ji C; Casinghino S; McCarthy TL; Centrella M
    J Biol Chem; 1997 Aug; 272(34):21260-7. PubMed ID: 9261136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sp1 and Sp3 transcription factors mediate interleukin-1 beta down-regulation of human type II collagen gene expression in articular chondrocytes.
    Chadjichristos C; Ghayor C; Kypriotou M; Martin G; Renard E; Ala-Kokko L; Suske G; de Crombrugghe B; Pujol JP; Galéra P
    J Biol Chem; 2003 Oct; 278(41):39762-72. PubMed ID: 12888570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction in transforming growth factor-beta type II receptor in mouse lung carcinogenesis.
    Jakowlew SB; Moody TW; You L; Mariano JM
    Mol Carcinog; 1998 May; 22(1):46-56. PubMed ID: 9609100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cooperative binding of transforming growth factor (TGF)-beta 2 to the types I and II TGF-beta receptors.
    Rodriguez C; Chen F; Weinberg RA; Lodish HF
    J Biol Chem; 1995 Jul; 270(27):15919-22. PubMed ID: 7608141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and autoregulation of transforming growth factor beta receptor mRNA in small-cell lung cancer cell lines.
    Nørgaard P; Spang-Thomsen M; Poulsen HS
    Br J Cancer; 1996 May; 73(9):1037-43. PubMed ID: 8624260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional regulation of cell-specific expression of the human cystathionine beta -synthase gene by differential binding of Sp1/Sp3 to the -1b promoter.
    Ge Y; Matherly LH; Taub JW
    J Biol Chem; 2001 Nov; 276(47):43570-9. PubMed ID: 11562358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-beta receptors in human cancer cell lines: analysis of transcript, protein and proliferation.
    Jakowlew SB; Moody TW; Mariano JM
    Anticancer Res; 1997; 17(3C):1849-60. PubMed ID: 9216635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations of transforming growth factor beta1 (TGF-beta1) and TGFbeta receptor expressions with progression in Dunning rat prostatic adenocarcinoma sublines.
    Wikström P; Lindh G; Bergh A; Damber JE
    Urol Res; 1999 Jun; 27(3):185-93. PubMed ID: 10422820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the integrin subunit alpha5 gene promoter by the transcription factors Sp1/Sp3 is influenced by the cell density in rabbit corneal epithelial cells.
    Gingras ME; Larouche K; Larouche N; Leclerc S; Salesse C; Guérin SL
    Invest Ophthalmol Vis Sci; 2003 Sep; 44(9):3742-55. PubMed ID: 12939287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.